New hope for Late-Stroke patients: drug before procedure may boost recovery

NCT ID NCT06987305

Recruiting now Disease control Sponsor: Xinqiao Hospital of Chongqing Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving a clot-busting drug (rhTNK-tPA) before a clot-removal procedure helps stroke patients who arrive 4.5 to 24 hours after symptoms start. About 820 adults with a blocked large artery in the brain will receive either the drug or a placebo. The goal is to see if the drug improves blood flow and leads to better recovery at 90 days, while also checking for risks like bleeding in the brain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE WITH LARGE VESSEL OCCLUSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebral artery occlusion ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

STROKE, ACUTE ISCHEMIC

Contacts and locations

Locations

Jiujiang First People's Hospital
RECRUITING

Jiujiang, Jiangxi, China
The First Affiliated Hospital of Nanchang University
RECRUITING

Nanchang, Jiangxi, China
Wuhan No. 1 Hospital
RECRUITING

Wuhan, Hubei, 430000, China
Xiangtan Central Hospital
RECRUITING

Xiangtan, Hunan, 421001, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.